Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Breath of Innovation® - Verona |
Description | Vision Strategy Company Leadership Corporate Governance About Ensifentrine Patients Stock Information News & SEC Filings Events & Presentations Financial |
Keywords | N/A |
WebSite | veronapharma.com |
Host IP | 68.183.255.50 |
Location | United States |
Site | Rank |
US$10,131,409
Last updated: 2023-04-30 19:29:26
veronapharma.com has Semrush global rank of 1,044,702. veronapharma.com has an estimated worth of US$ 10,131,409, based on its estimated Ads revenue. veronapharma.com receives approximately 1,169,009 unique visitors each day. Its web server is located in United States, with IP address 68.183.255.50. According to SiteAdvisor, veronapharma.com is safe to visit. |
Purchase/Sale Value | US$10,131,409 |
Daily Ads Revenue | US$9,353 |
Monthly Ads Revenue | US$280,563 |
Yearly Ads Revenue | US$3,366,746 |
Daily Unique Visitors | 77,934 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
veronapharma.com. | A | 8599 | IP: 68.183.255.50 |
veronapharma.com. | NS | 3600 | NS Record: ns74.domaincontrol.com. |
veronapharma.com. | NS | 3600 | NS Record: ns73.domaincontrol.com. |
veronapharma.com. | MX | 8600 | MX Record: 10 eu-smtp-inbound-1.mimecast.com. |
veronapharma.com. | MX | 8600 | MX Record: 10 eu-smtp-inbound-2.mimecast.com. |
veronapharma.com. | TXT | 8600 | TXT Record: MS=ms72977124 |
veronapharma.com. | TXT | 8600 | TXT Record: o/0CoteHibqCr883bJOQ4LZFwTk4EhzZn6S2YTELXyzRH4cpeK1428BuhRwy62F3DeT97EhJBB0C56n/dugu7Q== |
veronapharma.com. | TXT | 8600 | TXT Record: diedsuvt01ofmmnih7qmh3bqe4 |
Vision Strategy Company Leadership Corporate Governance About Ensifentrine Patients Stock Information News & SEC Filings Events & Presentations Financial Results Analyst Coverage Shareholder Information Investors Media Job Openings Employee Benefits Mission Statement Careers Contact Breath of Innovation® Verona Pharma is developing life enhancing treatments for chronic respiratory diseases. Verona Pharma Announces Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial for COPD Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023 Find out more We’re a clinical‑stage biopharmaceutical company focused on developing and commercializing innovative prescription medicines. We are focused on treating respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma. The |
HTTP/1.1 301 Moved Permanently Server: nginx/1.17.9 Date: Sat, 23 Oct 2021 12:33:07 GMT Content-Type: text/html Content-Length: 169 Connection: keep-alive Location: https://veronapharma.com/ HTTP/2 301 server: nginx/1.17.9 date: Sat, 23 Oct 2021 12:33:07 GMT content-type: text/html content-length: 169 location: https://www.veronapharma.com/ strict-transport-security: max-age=31536000 HTTP/2 200 server: nginx/1.17.9 date: Sat, 23 Oct 2021 12:33:08 GMT content-type: text/html; charset=utf-8 content-length: 37270 x-powered-by: Express cache-control: no-cache, no-store, must-revalidate x-cache-status: HIT x-cache-expired-at: 363d 46m 51.7s etag: "9f02-qDtUSddoHQNWbPPN10tSdsFSTsY" strict-transport-security: max-age=31536000 |
Domain Name: VERONAPHARMA.COM Registry Domain ID: 334071742_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.123-reg.co.uk Registrar URL: http://www.meshdigital.com Updated Date: 2021-02-09T17:29:57Z Creation Date: 2006-02-03T06:02:23Z Registry Expiry Date: 2024-02-03T06:02:23Z Registrar: 123-Reg Limited Registrar IANA ID: 1515 Domain Status: ok https://icann.org/epp#ok Name Server: NS73.DOMAINCONTROL.COM Name Server: NS74.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T23:28:51Z <<< |